Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice

Article

Abstract: The SARS-CoV-2 pandemic continues despite the presence of effective vaccines, and novel vaccine appr

Palabras claves:

Adaptive immunity, covid-19, Mucosal adjuvant, RBD, SARS-COV-2, spike, Vaccine

Autores:

Deimel L.P., James W.S., Javier Gilbert Jaramillo, Liu S., Liu X., Sattentau Q.J.

Fuentes:

scopus